236 related articles for article (PubMed ID: 24720760)
1. Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China.
Huang Z; Zhang X; Lu H; Wu L; Wang D; Zhang Q; Ding H
BMC Gastroenterol; 2014 Apr; 14():74. PubMed ID: 24720760
[TBL] [Abstract][Full Text] [Related]
2. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.
Aikou S; Ohmoto Y; Gunji T; Matsuhashi N; Ohtsu H; Miura H; Kubota K; Yamagata Y; Seto Y; Nakajima A; Goldenring JR; Kaminishi M; Nomura S
Gastroenterology; 2011 Sep; 141(3):837-845.e1-7. PubMed ID: 21699780
[TBL] [Abstract][Full Text] [Related]
3. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk.
Kaise M; Miwa J; Tashiro J; Ohmoto Y; Morimoto S; Kato M; Urashima M; Ikegami M; Tajiri H
J Gastroenterol; 2011 Jun; 46(6):736-45. PubMed ID: 21455714
[TBL] [Abstract][Full Text] [Related]
4. Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker.
Kaise M; Miwa J; Fujimoto A; Tashiro J; Tagami D; Sano H; Ohmoto Y
Gastric Cancer; 2013 Jul; 16(3):329-37. PubMed ID: 22907485
[TBL] [Abstract][Full Text] [Related]
5. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.
Lee JY; Park KS; Lee HG; Baek WK; Cho KB; Lee YJ; Lee YS; Ryu SW
Clin Exp Med; 2017 Aug; 17(3):403-410. PubMed ID: 27154568
[TBL] [Abstract][Full Text] [Related]
7. The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China.
Zhang XM; Li JX; Zhang GY; Li XH; Gu H
BMC Gastroenterol; 2014 Jan; 14():3. PubMed ID: 24383519
[TBL] [Abstract][Full Text] [Related]
8. Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.
Qu Y; Yang Y; Ma D; Xiao W
Oncol Rep; 2012 Apr; 27(4):1277-83. PubMed ID: 22246423
[TBL] [Abstract][Full Text] [Related]
9. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
[TBL] [Abstract][Full Text] [Related]
11. Promoter polymorphisms in trefoil factor 2 and trefoil factor 3 genes and susceptibility to gastric cancer and atrophic gastritis among Chinese population.
Xu Q; Chen MY; He CY; Sun LP; Yuan Y
Gene; 2013 Oct; 529(1):104-12. PubMed ID: 23933418
[TBL] [Abstract][Full Text] [Related]
12. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China.
Sun LP; Gong YH; Wang L; Yuan Y
World J Gastroenterol; 2007 Dec; 13(48):6562-7. PubMed ID: 18161928
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of serum pepsinogen I , II and osteopontin co-detection in gastric cancer screening].
Gong YH; Sun LP; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):691-3. PubMed ID: 17274377
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study.
Xu Y; Miremadi A; Link A; Malfertheiner P; Fitzgerald RC; Bornschein J
J Clin Pathol; 2019 Dec; 72(12):825-829. PubMed ID: 31235543
[TBL] [Abstract][Full Text] [Related]
15. Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.
Ishibashi Y; Ohtsu H; Ikemura M; Kikuchi Y; Niwa T; Nishioka K; Uchida Y; Miura H; Aikou S; Gunji T; Matsuhashi N; Ohmoto Y; Sasaki T; Seto Y; Ogawa T; Tada K; Nomura S
Sci Rep; 2017 Jul; 7(1):4846. PubMed ID: 28687783
[TBL] [Abstract][Full Text] [Related]
16. Serum pepsinogen II is a better diagnostic marker in gastric cancer.
Cao XY; Jia ZF; Jin MS; Cao DH; Kong F; Suo J; Jiang J
World J Gastroenterol; 2012 Dec; 18(48):7357-61. PubMed ID: 23326145
[TBL] [Abstract][Full Text] [Related]
17. Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.
Miftahussurur M; Waskito LA; Aftab H; Vilaichone RK; Subsomwong P; Nusi IA; Syam AF; Ratanachu-Ek T; Doohan D; Siregar G; Rezkitha YAA; Fauzia KA; Mahachai V; Yamaoka Y
PLoS One; 2020; 15(4):e0230064. PubMed ID: 32271765
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
[TBL] [Abstract][Full Text] [Related]
19. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study.
So JB; Yeoh KG; Moochala S; Chachlani N; Ho J; Wong WK; Mack P; Goh PM
Gastric Cancer; 2002; 5(4):228-32. PubMed ID: 12491081
[TBL] [Abstract][Full Text] [Related]
20. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
